Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
May 10 RCUS Arcus Biosciences First Quarter 2024 Earnings: Beats Expectations
May 9 ATRA Atara Biotherapeutics GAAP EPS of -$0.23 beats by $0.02, revenue of $27.36M beats by $2.67M
May 9 ATRA Atara Biotherapeutics (ATRA) Reports Q1 Loss, Tops Revenue Estimates
May 9 ATRA Atara Biotherapeutics Announces First Quarter 2024 Financial Results and Operational Progress
May 9 RCUS Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2024 Earnings Call Transcript
May 9 AXSM Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 9 AUPH Aurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024
May 9 RCUS Arcus Biosciences Inc (RCUS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
May 9 RCUS Arcus Biosciences, Inc. (RCUS) Q1 2024 Earnings Call Transcript
May 8 RCUS Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Tops Revenue Estimates
May 8 RCUS Arcus Biosciences GAAP EPS of -$0.05 beats by $0.92, revenue of $145M beats by $116.23M
May 8 RCUS Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update
May 8 AXSM Axsome Therapeutics to Present at Upcoming Investor Conferences
May 7 RCUS Arcus Biosciences Q1 2024 Earnings Preview
May 7 AXSM Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
May 7 AXSM Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript
May 7 AUPH How Much Upside is Left in Aurinia (AUPH)? Wall Street Analysts Think 96.51%
May 7 ALNY Alnylam Issues 2023 Corporate Responsibility Report
May 7 AUPH Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference
May 7 AXSM Axsome Therapeutics Inc (AXSM) (Q1 2024) Earnings Call Transcript Highlights: Soaring Revenues ...
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags